Glu-COACH: a Peer-mentoring Intervention to Reduce Disparities in Continuous Glucose Monitor (CGM) Use

Launched by YALE UNIVERSITY · Dec 5, 2023

Keywords

ClinConnect Summary

The Glu-COACH trial is a study designed to help Black and Latinx teens with type 1 diabetes learn how to use a continuous glucose monitor (CGM) device more effectively. A CGM is a tool that helps people manage their diabetes by tracking their blood sugar levels throughout the day, which can lead to better health outcomes. This study will pair participants with peer mentors—other young people who understand the challenges of diabetes—to provide support and encouragement in starting and maintaining CGM use. The goal is to reduce the gap in CGM usage among adolescents of color.

To be eligible for the study, participants should be between 11 and 19 years old, diagnosed with type 1 diabetes, and identify as Black and/or Latinx. They need to be able to communicate in English and have access to a smartphone or tablet for video sessions with their mentor. Importantly, they should not currently use a CGM. Participants can expect to engage in mentoring sessions and complete surveys about their experiences. This study is an exciting opportunity for young people to receive support and improve their diabetes management through the use of cutting-edge technology.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Diagnosis of type 1 diabetes, as determined clinically by the presence of ketosis or ketoacidosis at presentation and/or the presence of at least one diabetes-related auto-antibody
• • Self-identification as Black and/or Latinx.
• • Ability of participant to comprehend and communicate in written and spoken English, in order to complete surveys and participate in mentioning sessions and other interview (parents/caregivers do not need to have English fluency)
• • Access to personal cellphone or tablet to participate in remote video sessions with the peer mentor
• • using CGM \<50% of the time over the last 3 months
• Exclusion Criteria:
• • Participants with a prior severe skin reaction to CGM sensor or adhesive.
• • Current use of CGM
• • Current or planned pregnancy
• • Inability to comprehend or communicate in spoken/written English
• • Subjects with other medical or mental health conditions that would, in the opinion of the investigators, interfere with the conduct of the study or present additional risk to the individual.